The global SAFE-BioPharma digital identity and signature standard is being incorporated into the InnovoCommerce eClinical product suite used by pharmaceutical companies for their enterprise and investigator portal initiatives. InnovoCommerce is a source of eClinical collaboration products and solutions. It also has joined SAFE-BioPharma Association’s Vendor Partner program.
“Standardized identity management is essential to effective trial collaboration,” said Daniel O’Connor, president and chief business officer, InnovoCommerce. “Making InnovoPoint compliant with the SAFE-BioPharma standard will allow sponsor companies to manage collaborative exchanges with sites enabling greater productivity, quality and compliance.” InnovoPoint is the company’s clinical investigator portal commercial off-the-shelf product.
SAFE-BioPharma Association is the nonprofit industry coalition responsible for the ongoing development and implementation of the SAFE-BioPharma standard. High assurance digital identity credentials based on the standard are used in the biopharmaceutical and healthcare sectors to sign electronic documents and data files and to authenticate to online applications. Association members include Abbott, Astellas, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, Merck, Pfizer, Roche and Sanofi.
The standard is being incorporated into InnovoPoint, which helps pharmaceutical companies achieve the external collaboration required to manage globally distributed clinical trials in a cost-effective and efficient manner.